Skip to main content

  • Wednesday, Jun 21st
    3:30 PM – 3:45 PM  
    Removal of Endogenous TCR Chains for Tcr-based Immunotherapies
    Location: Salon A-D
    Presenting Author: Giorgia Zanetti – Columbia University
    Immuno-oncology
  • Wednesday, Jun 21st
    4:15 PM – 4:30 PM  
    FOXp3+ Regulatory T Cells Co-localize with CD8+ T Cells in Tumors Responding to PD-1 Blockade
    Location: Salon A-D
    Presenting Author: Mikhael Attias – McGill University
    Immuno-oncology
  • Wednesday, Jun 21st
    4:30 PM – 4:45 PM  
    Local and Systemic Immune Response Against Tumor Specific and Tumor-associated Antigens in Patients with Localized Uveal Melanoma (UM)
    Location: Salon A-D
    Presenting Author: Ana I. Lalanne, Ph.D. – Institut Curie
    Immuno-oncology
  • Wednesday, Jun 21st
    4:45 PM – 5:00 PM  
    Immuno-stat Platform: Tcr-selective Engagers for Selective Targeting of IL-2 to Tumor-specific T Cells
    Location: Salon A-D
    Presenting Author: Steven Quayle, Ph.D. – Cue Biopharma
    Immuno-oncology
  • Wednesday, Jun 21st
    5:15 PM – 5:30 PM  
    Antibodies to PODXL as an Approach to Targeting Tumor Stem Cells
    Location: Salon A-D
    Presenting Author: Kelly M. McNagny, PhD – University of British Columbia
    Immuno-oncology
  • Thursday, Jun 22nd
    3:45 PM – 4:00 PM  
    The FAM72 Gene Family Promotes Cancer Development by Disabling the Base Excision Repair System
    Location: Salon H-K
    Presenting Author: Alberto Martin, Ph.D. – University of Toronto
    Immuno-oncology